Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Prestige Consumer Healthcare (PBH)

Prestige Consumer Healthcare Q2 revenue falls 3.4% to $274.1 million; EPS outlook narrowed

Mixed Impact 3 of 5 earnings Written later

Prestige Consumer Healthcare reported fiscal second-quarter 2026 revenue of $274.1 million, down 3.4% from a year earlier, mainly due to limited ability to supply Clear Eyes. GAAP diluted EPS fell to $0.86 from $1.09, and adjusted diluted EPS was $1.07 versus $1.09. The company narrowed its fiscal 2026 adjusted EPS outlook to $4.54 to $4.58 from $4.50 to $4.58, while its revenue outlook was unchanged.

Key points

  • Q2 revenue $274.1 million vs. $283.8 million a year earlier; GAAP net income $42.2 million vs. $54.4 million
  • Q2 diluted EPS $0.86 (GAAP) and $1.07 (adjusted), vs. $1.09 in the prior-year quarter
  • Fiscal 2026 adjusted diluted EPS outlook $4.54 to $4.58, up from $4.50 to $4.58; revenue outlook $1,100 to $1,115 million unchanged
  • Repurchased about 1.1 million shares for about $75.0 million in Q2; net debt about $0.9 billion

The filing

CompanyPrestige Consumer Healthcare (PBH)
Form8-K, current report
Filed with the SECNov 6, 2025, 6:03 AM ET
Accession number0001295947-25-000037

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.